Down > 20% In Less Than A Month, Time To Buy The Dip In TransMedics Stock?

TMDX: TransMedics logo
TMDX
TransMedics

TransMedics stock has fallen by 21.4% in less than a month, from levels of $143.04 on 6/12/2025 to $112.46 now. Should you buy this dip? Dip buying is a viable strategy for quality stocks when broad market conditions are favorable, provided that the stock has a history of recovering from dips.

As it turns out, not only does TransMedics pass basic fundamental quality checks, but it has also returned (on average) 106% in one year, and 140% as peak return following sharp dips (>30% in 30 days) historically. That said, if you seek upside with lower volatility than individual stocks, the Trefis High Quality portfolio presents an alternative – having outperformed the S&P 500 and generated returns exceeding 91% since its inception.

Historical Median Returns Post Dips

 

Period Past Median Return
1M -11.6%
3M 10.6%
6M 18.4%
12M 146.9%

Historical Dip-Wise Details

TMDX had 5 events since 1/1/2020 where the dip threshold of -30% within 30 days was triggered

Relevant Articles
  1. What’s Behind SoFi Stock’s 101% Surge?
  2. Why Has Newmont Stock Surged 135%?
  3. Why Did Okta Stock Drop 20%?
  4. Salesforce’s Pivot: Why “Agentforce” Matters More Than the Earnings Beat
  5. RBRK Stock Analysis: Strong Growth Meets Rich Valuation
  6. Why Zscaler’s 27% Crash Is the Ultimate Test for Software Investors

  • 182% median peak return within 1 year of dip event
  • 350 days is the median time to peak return after a dip event
  • -39% median max drawdown within 1 year of dip event

 

30 Day Dip TMDX Subsequent Performance
Date TMDX SPY 1Y Peak
Return
Max
Drop
# Days
to Peak
Median 147% 182% -39% 350
10292024 -43% 4% 27% 62% -36% 226
8242023 -31% -3% 173% 182% -41% 365
12172021 -34% -1% 168% 211% -39% 350
4272021 -32% 6% -29% 18% -57% 73
3092020 -31% -17% 147% 187% -24% 358

TransMedics Passes Basic Financial Quality Checks

Revenue growth, profitability, cash flow, and balance sheet strength need to be evaluated to reduce the risk of a dip being the sign of a deteriorating business situation.

Quality Metrics Value Quality Check
Revenue Growth (LTM) 64.4% Pass
Revenue Growth (3-Yr Avg) 139.5% Pass
Operating Cash Flow Margin (LTM) 10.1% Pass
Leverage (see below) Pass
=> Interest Coverage Ratio 4.5
=> Cash To Interest Expense Ratio 21.7

Dip buying, while attractive, needs to be evaluated carefully from multiple angles. Such multi-factor analysis is exactly how we construct Trefis portfolio strategies. If you want upside with a smoother ride than an individual stock, consider the High Quality portfolio, which has outperformed the S&P, and clocked >91% returns since inception.